<?xml version="1.0" encoding="UTF-8" ?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/topics/PH06_en.shtml">
  <title>Market Research Reports for Bone Disease Treatment</title>
  <link>http://www.giiresearch.com/topics/PH06_en.shtml</link>
  <description>Market Research Reports for Bone Disease Treatment</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2013 Global Information, Inc.</dc:rights>
  <dc:date>2013-05-23</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267072-pharmapoint-osteoporosis-us-drug-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267073-pharmapoint-osteoporosis-france-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267074-pharmapoint-osteoporosis-germany-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267075-pharmapoint-osteoporosis-italy-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267076-pharmapoint-osteoporosis-spain-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267077-pharmapoint-osteoporosis-uk-drug-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267078-pharmapoint-osteoporosis-japan-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267079-pharmapoint-osteoporosis-india-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd267080-pharmapoint-osteoporosis-china-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc263116-osteoporosis-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd260972-epicast-report-osteoporosis-epidemiology-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr256871-drg-insights-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd217849-osteopenia-global-clinical-trials-review-h2-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc250568-treatment-algorithms-osteoporosis-condition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi244534-bone-metabolism-therapeutics-market-2018.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi242745-global-musculoskeletal-drugs-market-2011-2015.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/go243051-osteoporosis-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm234942-osteoporosis-drug-market-global-china-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm234940-china-osteoporosis-market-analysis-forecast-2007.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi227860-musculoskeletal-disorders-therapeutics-market-2017.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd222446-osteoarthritis-therapeutics-pipeline-assessment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc180915-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc203575-product-profiles-osteoporosis-novel-candidates.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc207802-key-companies-osteoporosis-growing-competition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc229430-market-product-forecast-osteoporosis-prolia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd217226-multiple-myeloma-therapeutics-pipeline-assessment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/go225235-multiple-myeloma-therapeutics.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ren210160-global-osteoporosis-market-drugs-analysis-2010.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/med201350-worldwide-spine-surgery-2011-products-technologies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc206499-epidemiology-osteopenia-osteoporosis-on-rise-aging.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd200530-myelodysplastic-syndrome-therapeutics-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd196167-osteoporosis-global-clinical-trials-review-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd180368-bone.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lsa106046-osteoarthritis-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lsa106057-osteoporosis-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lsa106059-muscle-pain.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lsa106060-gout-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/lsa106068-disease-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi170800-bone-joint-infection.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/mh129389-us-muscu-tissue.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc125940-therapeu-bio-mtrl.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc134477-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc134493-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc121231-osteoporosis-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt120864-bone-meta-disorder.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc94599-osteoporosis-novel.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs75358-euro-bone.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs69882-us-osteoporosis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs52983-osteoarthritis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs52130-spinal-surgery.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ti51761-dexa.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs50687-multiple-myeloma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/ti45783-emerging.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs45015-bone-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es40072-musculoskeletal.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Osteoporosis Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86342-ch-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2013-04-19</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Rheumatoid Arthritis (RA): World Drug Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt220557-rheumatoid-arthritis-world-drug-market-2011-2021.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267072-pharmapoint-osteoporosis-us-drug-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267072-pharmapoint-osteoporosis-us-drug-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267073-pharmapoint-osteoporosis-france-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267073-pharmapoint-osteoporosis-france-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267074-pharmapoint-osteoporosis-germany-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - Germany Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267074-pharmapoint-osteoporosis-germany-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267075-pharmapoint-osteoporosis-italy-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - Italy Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267075-pharmapoint-osteoporosis-italy-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267076-pharmapoint-osteoporosis-spain-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267076-pharmapoint-osteoporosis-spain-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267077-pharmapoint-osteoporosis-uk-drug-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - UK Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267077-pharmapoint-osteoporosis-uk-drug-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267078-pharmapoint-osteoporosis-japan-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - Japan Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267078-pharmapoint-osteoporosis-japan-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267079-pharmapoint-osteoporosis-india-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267079-pharmapoint-osteoporosis-india-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd267080-pharmapoint-osteoporosis-china-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-02-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Osteoporosis - China Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd267080-pharmapoint-osteoporosis-china-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc263116-osteoporosis-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2013-01-17</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>The Osteoporosis Market Outlook to 2021</title>
  <link>http://www.giiresearch.com/report/dc263116-osteoporosis-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd260972-epicast-report-osteoporosis-epidemiology-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>EpiCast Report: Osteoporosis - Epidemiology Forecast to 2022</title>
  <link>http://www.giiresearch.com/report/gd260972-epicast-report-osteoporosis-epidemiology-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr256871-drg-insights-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-11-15</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>DRG Insights: Osteoporosis</title>
  <link>http://www.giiresearch.com/report/dr256871-drg-insights-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd217849-osteopenia-global-clinical-trials-review-h2-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-09-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Osteopenia Global Clinical Trials Review, H2, 2012</title>
  <link>http://www.giiresearch.com/report/gd217849-osteopenia-global-clinical-trials-review-h2-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc250568-treatment-algorithms-osteoporosis-condition.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-08-23</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Treatment Algorithms: Osteoporosis - A condition plagued by low diagnosis and treatment rates, low compliance, and the side effects of the key bisphosphonate class</title>
  <link>http://www.giiresearch.com/report/dc250568-treatment-algorithms-osteoporosis-condition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi244534-bone-metabolism-therapeutics-market-2018.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-06-12</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar</title>
  <link>http://www.giiresearch.com/report/gbi244534-bone-metabolism-therapeutics-market-2018.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi242745-global-musculoskeletal-drugs-market-2011-2015.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-05-21</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Musculoskeletal Drugs Market 2011-2015</title>
  <link>http://www.giiresearch.com/report/infi242745-global-musculoskeletal-drugs-market-2011-2015.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/go243051-osteoporosis-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-05-01</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Osteoporosis Therapeutics</title>
  <link>http://www.giiresearch.com/report/go243051-osteoporosis-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm234942-osteoporosis-drug-market-global-china-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-01-30</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)</title>
  <link>http://www.giiresearch.com/report/tsm234942-osteoporosis-drug-market-global-china-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm234940-china-osteoporosis-market-analysis-forecast-2007.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-01-16</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>China Osteoporosis Market Analysis and Forecast, 2007 - 2015</title>
  <link>http://www.giiresearch.com/report/tsm234940-china-osteoporosis-market-analysis-forecast-2007.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi227860-musculoskeletal-disorders-therapeutics-market-2017.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2012-01-06</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014</title>
  <link>http://www.giiresearch.com/report/gbi227860-musculoskeletal-disorders-therapeutics-market-2017.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd222446-osteoarthritis-therapeutics-pipeline-assessment.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-11-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
  <link>http://www.giiresearch.com/report/gd222446-osteoarthritis-therapeutics-pipeline-assessment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc180915-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>R&amp;D Trends: Osteoporosis - Strong pipeline bodes well for future treatment</title>
  <link>http://www.giiresearch.com/report/dc180915-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc203575-product-profiles-osteoporosis-novel-candidates.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Product Profiles: Osteoporosis - Novel candidates offer the greatest potential</title>
  <link>http://www.giiresearch.com/report/dc203575-product-profiles-osteoporosis-novel-candidates.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc207802-key-companies-osteoporosis-growing-competition.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Key Companies: Osteoporosis - Growing competition threatens leading franchises and drives innovation</title>
  <link>http://www.giiresearch.com/report/dc207802-key-companies-osteoporosis-growing-competition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc229430-market-product-forecast-osteoporosis-prolia.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-11-01</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Market and Product Forecast: Osteoporosis - Prolia and odanacatib to restore growth in the market</title>
  <link>http://www.giiresearch.com/report/dc229430-market-product-forecast-osteoporosis-prolia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd217226-multiple-myeloma-therapeutics-pipeline-assessment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-10-05</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
  <link>http://www.giiresearch.com/report/gd217226-multiple-myeloma-therapeutics-pipeline-assessment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/go225235-multiple-myeloma-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-10-01</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Multiple Myeloma Therapeutics</title>
  <link>http://www.giiresearch.com/report/go225235-multiple-myeloma-therapeutics.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ren210160-global-osteoporosis-market-drugs-analysis-2010.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-09-01</dc:date>
  <dc:creator>Renub Research</dc:creator>
  <title>Global Osteoporosis Market &amp; Drugs Analysis 2010 - 2015</title>
  <link>http://www.giiresearch.com/report/ren210160-global-osteoporosis-market-drugs-analysis-2010.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/med201350-worldwide-spine-surgery-2011-products-technologies.html">
  <dc:language>en</dc:language>
  <dc:subject>Orthopedic</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-07-30</dc:date>
  <dc:creator>MedMarket Diligence</dc:creator>
  <title>Worldwide Spine Surgery: Products, Technologies, Markets &amp; Opportunities, 2010-2020</title>
  <link>http://www.giiresearch.com/report/med201350-worldwide-spine-surgery-2011-products-technologies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc206499-epidemiology-osteopenia-osteoporosis-on-rise-aging.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-07-08</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Epidemiology: Osteopenia and Osteoporosis - On the rise as the aging population grows</title>
  <link>http://www.giiresearch.com/report/dc206499-epidemiology-osteopenia-osteoporosis-on-rise-aging.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd200530-myelodysplastic-syndrome-therapeutics-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-06-01</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017</title>
  <link>http://www.giiresearch.com/report/gd200530-myelodysplastic-syndrome-therapeutics-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd196167-osteoporosis-global-clinical-trials-review-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-04-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Osteoporosis Global Clinical Trials Review, Q1, 2011</title>
  <link>http://www.giiresearch.com/report/gd196167-osteoporosis-global-clinical-trials-review-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd180368-bone.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2011-04-01</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017</title>
  <link>http://www.giiresearch.com/report/gd180368-bone.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lsa106046-osteoarthritis-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-03-14</dc:date>
  <dc:creator>Life Science Analytics</dc:creator>
  <title>Osteoarthritis Therapy Area Pipeline Report</title>
  <link>http://www.giiresearch.com/report/lsa106046-osteoarthritis-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lsa106057-osteoporosis-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-03-14</dc:date>
  <dc:creator>Life Science Analytics</dc:creator>
  <title>Osteoporosis Therapy Area Pipeline Report</title>
  <link>http://www.giiresearch.com/report/lsa106057-osteoporosis-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lsa106059-muscle-pain.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-03-14</dc:date>
  <dc:creator>Life Science Analytics</dc:creator>
  <title>Muscle Pain Therapy Area Pipeline Report</title>
  <link>http://www.giiresearch.com/report/lsa106059-muscle-pain.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lsa106060-gout-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-03-14</dc:date>
  <dc:creator>Life Science Analytics</dc:creator>
  <title>Gout Therapy Area Pipeline Report</title>
  <link>http://www.giiresearch.com/report/lsa106060-gout-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/lsa106068-disease-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-03-14</dc:date>
  <dc:creator>Life Science Analytics</dc:creator>
  <title>Paget's Disease Therapy Area Pipeline Report</title>
  <link>http://www.giiresearch.com/report/lsa106068-disease-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi170800-bone-joint-infection.html">
  <dc:language>en</dc:language>
  <dc:subject>Infectious Disease</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2011-02-10</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment</title>
  <link>http://www.giiresearch.com/report/gbi170800-bone-joint-infection.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/mh129389-us-muscu-tissue.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Biomaterials</dc:subject>
  <dc:date>2010-07-31</dc:date>
  <dc:creator>Medtech Insight</dc:creator>
  <title>U.S. Markets for Musculoskeletal Tissue Engineering Products</title>
  <link>http://www.giiresearch.com/report/mh129389-us-muscu-tissue.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc125940-therapeu-bio-mtrl.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Biomaterials</dc:subject>
  <dc:date>2010-07-29</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Therapeutics and Biomaterials for Musculoskeletal Disease: Global Markets</title>
  <link>http://www.giiresearch.com/report/bc125940-therapeu-bio-mtrl.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc134477-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2010-07-21</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase</title>
  <link>http://www.giiresearch.com/report/dc134477-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc134493-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2010-07-21</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline</title>
  <link>http://www.giiresearch.com/report/dc134493-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc121231-osteoporosis-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2010-05-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Osteoporosis Drugs: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc121231-osteoporosis-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt120864-bone-meta-disorder.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2010-04-09</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Osteoporosis &amp; Bone Metabolism Disorders: World Market 2010-2025</title>
  <link>http://www.giiresearch.com/report/kt120864-bone-meta-disorder.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc94599-osteoporosis-novel.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2009-07-13</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pipeline and Commercial Insight: Osteoporosis Novel agents to battle for payer acceptance</title>
  <link>http://www.giiresearch.com/report/dc94599-osteoporosis-novel.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs75358-euro-bone.html">
  <dc:language>en</dc:language>
  <dc:subject>Orthopedic</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2008-10-13</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Bone Growth and Spinal Fusion Stimulators Markets</title>
  <link>http://www.giiresearch.com/report/fs75358-euro-bone.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs69882-us-osteoporosis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2008-06-26</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Osteoporosis Market</title>
  <link>http://www.giiresearch.com/report/fs69882-us-osteoporosis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs52983-osteoarthritis.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2007-06-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Osteoarthritis Markets</title>
  <link>http://www.giiresearch.com/report/fs52983-osteoarthritis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs52130-spinal-surgery.html">
  <dc:language>en</dc:language>
  <dc:subject>Orthopedic</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2007-05-21</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Spinal Surgery Markets</title>
  <link>http://www.giiresearch.com/report/fs52130-spinal-surgery.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ti51761-dexa.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2007-03-31</dc:date>
  <dc:creator>Technical Insights (Frost &amp; Sullivan)</dc:creator>
  <title>Advances in DEXA</title>
  <link>http://www.giiresearch.com/report/ti51761-dexa.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs50687-multiple-myeloma.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2007-03-27</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Multiple Myeloma Market</title>
  <link>http://www.giiresearch.com/report/fs50687-multiple-myeloma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/ti45783-emerging.html">
  <dc:language>en</dc:language>
  <dc:subject>Orthopedic</dc:subject>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2006-09-30</dc:date>
  <dc:creator>Technical Insights (Frost &amp; Sullivan)</dc:creator>
  <title>Emerging Technologies for the Spine Market</title>
  <link>http://www.giiresearch.com/report/ti45783-emerging.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs45015-bone-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:date>2006-08-22</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Bone Growth &amp; Spinal Fusion Stimulators Markets</title>
  <link>http://www.giiresearch.com/report/fs45015-bone-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es40072-musculoskeletal.html">
  <dc:language>en</dc:language>
  <dc:subject>Bone Disease Treatment</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2006-05-19</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>New Drug Futures: Musculoskeletal</title>
  <link>http://www.giiresearch.com/report/es40072-musculoskeletal.html</link>
  <description></description>
</item>
</rdf:RDF>